Saeki H - Search Results

1

Efficacy and feasibility of S-1 plus oxaliplatin (C-SOX) for treating patients with stage III colon cancer (KSCC1303): final analysis of 3-year disease-free survival.

Ando K, Emi Y, Miyanari N, Tsuji A, Sakai K, Sawai T, Imamura H, Mori S, Tokunaga S, Oki E, Saeki H, Kakeji Y, Akagi Y, Baba H, Maehara Y, Mori M; Kyushu Study Group of Clinical Cancer (KSCC). Ando K, et al. Among authors: saeki h. Int J Clin Oncol. 2020 Jun;25(6):1115-1122. doi: 10.1007/s10147-020-01646-5. Epub 2020 Mar 18. Int J Clin Oncol. 2020. PMID: 32189156 Clinical Trial.

2

Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract.

Morita M, Saeki H, Mori M, Kuwano H, Sugimachi K. Morita M, et al. Among authors: saeki h. Surgery. 2002 Jan;131(1 Suppl):S1-6. doi: 10.1067/msy.2002.119287. Surgery. 2002. PMID: 11821780 Review.

3

Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer.

Saeki H, Oda S, Kawaguchi H, Ohno S, Kuwano H, Maehara Y, Sugimachi K. Saeki H, et al. Int J Cancer. 2002 Mar 1;98(1):8-13. doi: 10.1002/ijc.10163. Int J Cancer. 2002. PMID: 11857377

4

Early report of correlation between the thermal dosage and the treatment effect of hyperthermia in combination with chemoradiotherapy for esophageal cancer patients.

Kitamura K, Ishida M, Kimura Y, Saeki H, Maehara Y, Sugimachi K. Kitamura K, et al. Among authors: saeki h. Hepatogastroenterology. 2002 Nov-Dec;49(48):1560-2. Hepatogastroenterology. 2002. PMID: 12397735

5

[Evaluation of multi-modality treatment for the patients with advanced esophageal cancer].

Saeki H, Ohga T, Ito S, Futatsugi M, Kimura Y, Kakeji Y, Maehara Y, Nakamura K, Shioyama Y. Saeki H, et al. Fukuoka Igaku Zasshi. 2002 Dec;93(12):259-65. Fukuoka Igaku Zasshi. 2002. PMID: 12632630 Japanese.

6

Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus - significance as a tumor marker.

Nozoe T, Korenaga D, Futatsugi M, Saeki H, Maehara Y, Sugimachi K. Nozoe T, et al. Among authors: saeki h. Cancer Lett. 2003 Mar 20;192(1):89-95. doi: 10.1016/s0304-3835(02)00630-4. Cancer Lett. 2003. PMID: 12637157

7

Risk factors for multicentric occurrence of carcinoma in the upper aerodigestive tract-analysis with a serial histologic evaluation of the whole resected-esophagus including carcinoma.

Morita M, Araki K, Saeki H, Sakaguchi Y, Baba H, Sugimachi K, Yano K, Sugio K, Yasumoto K. Morita M, et al. Among authors: saeki h. J Surg Oncol. 2003 Aug;83(4):216-21. doi: 10.1002/jso.10276. J Surg Oncol. 2003. PMID: 12884233

8

Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma.

Kimura Y, Watanabe M, Ohga T, Saeki H, Kakeji Y, Baba H, Maehara Y. Kimura Y, et al. Among authors: saeki h. Oncol Rep. 2003 Nov-Dec;10(6):1747-51. doi: 10.3892/or.10.6.1747. Oncol Rep. 2003. PMID: 14534690

9

p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.

Ito S, Ohga T, Saeki H, Nakamura T, Watanabe M, Tanaka S, Kakeji Y, Maehara Y. Ito S, et al. Among authors: saeki h. Int J Cancer. 2005 Jan 1;113(1):22-8. doi: 10.1002/ijc.20500. Int J Cancer. 2005. PMID: 15386362

10

Clinical outcomes of FOLFOX/FOLFIRI for the Japanese patients with far-advanced or recurrent colorectal cancer.

Saeki H, Higashi H, Maehara S, Tanaka J, Makino I, Imamura S, Aso M, Katoh H, Kakeji Y, Maehara Y. Saeki H, et al. Fukuoka Igaku Zasshi. 2007 Jun;98(6):253-9. Fukuoka Igaku Zasshi. 2007. PMID: 17665546 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,267 results

Search Page

Filters